Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes
- PMID: 26773011
- PMCID: PMC4717871
- DOI: 10.3945/an.114.007955
Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes
Abstract
Our understanding of the impact of poor hepatic choline/phosphatidylcholine availability in promoting the steatosis characteristic of human nonalcoholic fatty liver disease (NAFLD) has recently advanced and possibly relates to phosphatidylcholine/phosphatidylethanolamine concentrations in various, membranes as well as cholesterol dysregulation. A role for choline/phosphatidylcholine availability in the progression of NAFLD to liver injury and serious hepatic consequences in some individuals requires further elucidation. There are many reasons for poor choline/phosphatidylcholine availability in the liver, including low intake, estrogen status, and genetic polymorphisms affecting, in particular, the pathway for hepatic de novo phosphatidylcholine synthesis. In addition to free choline, phosphatidylcholine has been identified as a substrate for trimethylamine production by certain intestinal bacteria, thereby reducing host choline bioavailability and providing an additional link to the increased risk of cardiovascular disease faced by those with NAFLD. Thus human choline requirements are highly individualized and biomarkers of choline status derived from metabolomics studies are required to predict those at risk of NAFLD induced by choline deficiency and to provide a basis for human intervention trials.
Keywords: NAFLD; choline; liver diseases; microbiome; nonalcoholic steatosis; phosphatidylcholine.
© 2016 American Society for Nutrition.
Conflict of interest statement
Author disclosures: JL Sherriff, TA O’Sullivan, C Properzi, J-L Oddo, and LA Adams, no conflicts of interest.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4717871/bin/an007955fig1.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4717871/bin/an007955fig2.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4717871/bin/an007955fig3.gif)
Similar articles
-
Hepatic PEMT Expression Decreases with Increasing NAFLD Severity.Int J Mol Sci. 2022 Aug 18;23(16):9296. doi: 10.3390/ijms23169296. Int J Mol Sci. 2022. PMID: 36012560 Free PMC article.
-
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G582-G609. doi: 10.1152/ajpgi.00344.2019. Epub 2020 Jan 31. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 32003601 Free PMC article.
-
One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics.Lifestyle Genom. 2020;13(2):53-63. doi: 10.1159/000504602. Epub 2019 Dec 17. Lifestyle Genom. 2020. PMID: 31846961 Review.
-
Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.Exp Biol Med (Maywood). 2015 Jun;240(6):809-20. doi: 10.1177/1535370215579161. Epub 2015 Apr 13. Exp Biol Med (Maywood). 2015. PMID: 25873078 Free PMC article. Review.
-
Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.Hepatology. 2012 Apr;55(4):1094-102. doi: 10.1002/hep.24782. Epub 2012 Feb 29. Hepatology. 2012. PMID: 22095799
Cited by
-
Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing.Front Pharmacol. 2024 Apr 19;15:1349244. doi: 10.3389/fphar.2024.1349244. eCollection 2024. Front Pharmacol. 2024. PMID: 38708085 Free PMC article.
-
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease.Drug Deliv Transl Res. 2024 Apr 13. doi: 10.1007/s13346-024-01576-z. Online ahead of print. Drug Deliv Transl Res. 2024. PMID: 38615156
-
Choline supplementation: Impact on broiler chicken performance, steatosis, and economic viability from from 1 to 42 days.PLoS One. 2024 Mar 19;19(3):e0295488. doi: 10.1371/journal.pone.0295488. eCollection 2024. PLoS One. 2024. PMID: 38502648 Free PMC article.
-
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence.Curr Nutr Rep. 2024 Jun;13(2):152-165. doi: 10.1007/s13668-024-00521-3. Epub 2024 Mar 1. Curr Nutr Rep. 2024. PMID: 38427291 Free PMC article. Review.
-
Supplementation with Silybum marianum Extract, Synbiotics, Omega-3 Fatty Acids, Vitamins, and Minerals: Impact on Biochemical Markers and Fecal Microbiome in Overweight Dogs.Animals (Basel). 2024 Feb 9;14(4):579. doi: 10.3390/ani14040579. Animals (Basel). 2024. PMID: 38396547 Free PMC article.
References
-
- Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res 2008;49:1187–94. - PubMed
-
- Jüngst D, Lang T, Huber P, Lange V, Paumgartner G. Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones. J Lipid Res 1993;34:1457–64. - PubMed
-
- Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 2006;83:5–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical